EE169 Cost to Achieve Seizures Reduction or Seizure Freedom in Dravet Syndrome in the USA: An Analysis Based on NNT (NUMBER NEEDED TO TREAT) of Stiripentol, Fenfluramine and Cannabidiol
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.468
https://www.valueinhealthjournal.com/article/S1098-3015(24)00583-7/fulltext
Title :
EE169 Cost to Achieve Seizures Reduction or Seizure Freedom in Dravet Syndrome in the USA: An Analysis Based on NNT (NUMBER NEEDED TO TREAT) of Stiripentol, Fenfluramine and Cannabidiol
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00583-7&doi=10.1016/j.jval.2024.03.468
First page :
Section Title :
Open access? :
No
Section Order :
11814